Bal Pharma Management
Management criteria checks 3/4
Bal Pharma's CEO is Shailesh Siroya, appointed in Aug 2019, has a tenure of 5.25 years. total yearly compensation is ₹10.20M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 19.27% of the company’s shares, worth ₹413.88M. The average tenure of the management team and the board of directors is 4.2 years and 4.5 years respectively.
Key information
Shailesh Siroya
Chief executive officer
₹10.2m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 5.3yrs |
| CEO ownership | 19.3% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹77m |
| Jun 30 2024 | n/a | n/a | ₹76m |
| Mar 31 2024 | ₹10m | ₹10m | ₹74m |
| Dec 31 2023 | n/a | n/a | ₹35m |
| Sep 30 2023 | n/a | n/a | ₹32m |
| Jun 30 2023 | n/a | n/a | ₹24m |
| Mar 31 2023 | ₹12m | ₹12m | ₹26m |
| Dec 31 2022 | n/a | n/a | ₹29m |
| Jun 30 2022 | n/a | n/a | ₹43m |
| Mar 31 2022 | ₹10m | ₹10m | ₹56m |
| Dec 31 2021 | n/a | n/a | ₹72m |
| Jun 30 2021 | n/a | n/a | ₹59m |
| Mar 31 2021 | ₹10m | ₹10m | ₹47m |
| Dec 31 2020 | n/a | n/a | -₹34m |
| Sep 30 2020 | n/a | n/a | -₹73m |
| Jun 30 2020 | n/a | n/a | -₹95m |
| Mar 31 2020 | ₹10m | ₹10m | -₹122m |
| Dec 31 2019 | n/a | n/a | -₹52m |
| Sep 30 2019 | n/a | n/a | -₹15m |
| Jun 30 2019 | n/a | n/a | -₹21m |
| Mar 31 2019 | ₹8m | ₹8m | ₹38m |
| Dec 31 2018 | n/a | n/a | ₹29m |
| Mar 31 2018 | ₹8m | ₹8m | ₹28m |
Compensation vs Market: Shailesh's total compensation ($USD120.80K) is above average for companies of similar size in the Indian market ($USD42.61K).
Compensation vs Earnings: Shailesh's compensation has been consistent with company performance over the past year.
CEO
Shailesh Siroya (58 yo)
5.3yrs
Tenure
₹10,200,000
Compensation
Mr. Shailesh Dheerajmal Siroya serves as the Managing Director of BAL Pharma Limited. Mr. Siroya served as the Managing Director of BAL Pharma Limited since August 1, 1994. With rich experience, Mr. Siroya...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 5.3yrs | ₹10.20m | 19.27% ₹ 413.9m | |
| Chief Financial Officer | no data | ₹2.60m | no data | |
| Company Secretary & Compliance Officer | 1.3yrs | ₹540.00k | no data | |
| Whole Time Director | 4.2yrs | ₹3.32m | 0.17% ₹ 3.6m | |
| Deputy General Manager of Internal Audit | no data | no data | no data | |
| Assistant Vice President of Sales & Marketing | no data | no data | no data | |
| Vice President of International Marketing & HR | no data | ₹534.34k | no data | |
| Whole Time Director | no data | ₹1.87m | no data |
4.2yrs
Average Tenure
59.5yo
Average Age
Experienced Management: 524824's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 27.2yrs | ₹10.20m | 19.27% ₹ 413.9m | |
| Whole Time Director | 5.2yrs | ₹3.32m | 0.17% ₹ 3.6m | |
| Whole Time Director | 2.5yrs | ₹1.87m | no data | |
| Independent Non-Executive Director | 4.5yrs | ₹52.00k | no data | |
| Non-Executive Additional Independent Director | 4.5yrs | ₹61.00k | no data | |
| Non-Executive Independent Director | 3.9yrs | ₹61.00k | no data |
4.5yrs
Average Tenure
63yo
Average Age
Experienced Board: 524824's board of directors are considered experienced (4.5 years average tenure).